Low-molecular-weight heparin vs. a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

By Lee A.Y.Y.   Levine M.N.   Baker R.I.   for the Randomized Comparison of Low-Molecular-Weight Heparin vs. Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer CLOT Investigators  

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 19-20

Elsevier

Access to resources Recommend Favorite

Prevention of Venous Thromboembolism - Prophylaxis with a low molecular weight heparin (Fragmin)

By Agnelli G.   Sonaglia F.  

Thrombosis Research, Vol. 97, Iss. 1, 2000-01 ,pp. : 49-62

Elsevier

Access to resources Recommend Favorite

Anti-thrombotic Efficacies of Enoxaparin, Dalteparin, and Unfractionated Heparin in Venous Thrombo-embolism

By Morris T.A.   Marsh J.J.   Konopka R.   Pedersen C.A.   Chiles P.G.  

Thrombosis Research, Vol. 100, Iss. 3, 2000-11 ,pp. : 185-194

Elsevier

Access to resources Recommend Favorite

Contraception. Recurrent use of newer oral contraceptives and the risk of venous thromboembolism

By Suissa S.  

Human Reproduction, Vol. 15, Iss. 4, 2000-04 ,pp. : 817-821

Oxford University Press

Access to resources Recommend Favorite

Multiple Sclerosis and Risk of Venous Thromboembolism: A Population-Based Cohort Study

By  

Neuroepidemiology, Vol. 38, Iss. 2, 2012-01 ,pp. : 76-83

Karger

Access to resources Recommend Favorite